Drug Pricing Dynamics and Media Accountability

This chapter explores the pressure to utilize marching rights for lowering drug prices during the Obama and Trump administrations, emphasizing the impact of high prices for COVID treatments. It also includes a critical discussion on the media's portrayal of ivermectin and the integrity of news reporting surrounding COVID treatments.